Novo Holdings

Novo Holdings is the holding and investment company of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. Its overriding strategy is to be a stable and supportive owner of the Novo Group, generate attractive long-term returns, and allocate a significant portion of funds to direct life science investing across all stages of development — from seed-stage company creation in Scandinavia through venture, growth, and large principal investments globally. Novo Holdings invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services, and industrial biosolutions, while also managing a diversified portfolio of equities, bonds, real estate, infrastructure, and private equity assets. As the firm states: 'We are committed to better healthcare and a greener future. We invest to promote groundbreaking solutions in healthcare and bio-sustainability.' With an evergreen structure and offices in Copenhagen, London, Boston, San Francisco, Singapore, Shanghai, and Mumbai, Novo Holdings brings capital, deep life science expertise, and a global network to its 170+ portfolio companies.